In 2017, we described the previous UK drug strategy as full of “false claims and empty promises.”1 The […]

AbstractObjectiveTo evaluate pathological complete response as a surrogate endpoint for disease-free survival and overall survival in regulatory neoadjuvant […]

The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types […]

With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten […]

It was a step too far for ninety nine Conservative MPs. They were simply unwilling to support the […]

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring […]

Remote monitoring of health-related behaviour with wearable sensor technology is feasible for people with complex health conditions, shows […]

GlaxoSmithKline reveals health fears of eosinophilic asthma patients, frustration of late diagnosis badams Mon, 12/20/2021 – 05:19

Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis sharon.coey Mon, 12/20/2021 – 07:20

After EMA recommendation, Novavax’s COVID-19 vaccine nears rollout in Europe fkansteiner Mon, 12/20/2021 – 07:54